The review process is similar to the development process (see Chapter 2) and will need careful planning and budgeting. A review committee should be set up and each chapter carefully assessed by an expert subcommittee charged with identifying information that needs changing either in the drug monographs, clinical guidance or additional information sections. This will include consideration of any suggestions received from users of the formulary.